200 reports

  • GLOBAL PREMATURE EJACULATION TREATMENT MARKET BY SSRIS 2016-2021 ($ MILLIONS)
  • SSRIS
  • Pharmaceutical
  • Therapy
  • Forecast
  • Market Size
  • Eli Lilly & Co.
  • NEURODEGENERATIVE DISORDERS THERAPEUTICS MARKET, COMORBIDITIES ASSOCIATED WITH
  • Clinical Trial
  • Dementia
  • Therapy
  • World
  • Biogen Idec Inc.
  • 4.5 Personality Disorders
  • 20 Personality disorders market, 2014 - 2025 (USD Billion)
  • Healthcare
  • Forecast
  • ASSET TRANSACTIONS
  • ACQUISITION

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Healthcare
  • Pharmaceutical
  • Therapy
  • United States
  • Kyowa Hakko Kirin Co., Ltd.
  • PIPELINE BY TAKEDA PHARMACEUTICAL CO LTD, H2 2017
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H2 2017

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Digestive System Disorder
  • Therapy
  • World
  • Product Initiative
  • Gilead Sciences, Inc.
  • KYOWA HAKKO KIRIN ENTERS INTO LICENSING AGREEMENT WITH SANDOZ

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Biosimilar
  • Pharmaceutical
  • GlobalData's company
  • Novartis AG
  • Sandoz Inc.
  • Description

disorder, Generalised anxiety disorder, Panic disorder, Post traumatic stress disorder, Attention deficit hyperactivity disorder, Bipolar disorder, Chronic fatigue syndrome, Cognitive impairment, Delirium, Dementia, Alzheimers, Dementia with lewy

  • Mental Health
  • Pathology
  • World
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H2 2017
  • PIPELINE BY HORIZON DISCOVERY GROUP PLC, H2 2017

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Cancer
  • Hospital
  • R&D
  • Research And Development
  • AstraZeneca PLC
  • UNIPOLAR DEPRESSION
  • Antipsychotic
  • Psychotic Disorder
  • AstraZeneca PLC
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • Description
  • Mental Health
  • Pathology
  • World
  • 2.3 GLOBAL TRENDS

The size and burden of mental disorders and other disorders of the brain in Europe 2010.

  • Mental Health
  • Pathology
  • Psychotic Disorder
  • Japan
  • Forecast
  • Products and services segmentation (2017)
  • KEY STATISTICS SNAPSHOT
  • Addictions
  • Mental Health
  • Pathology
  • Psychoactive Drug Consumption
  • Canada
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H1 2017
  • PIPELINE BY TAKEDA PHARMACEUTICAL COMPANY LTD, H1 2017

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Digestive System Disorder
  • Hormone
  • Therapy
  • World
  • Gilead Sciences, Inc.
  • GLOBAVIR BIOSCIENCES INC
  • PIPELINE BY GLOBAVIR BIOSCIENCES INC, H2 2017
  • Chemokine
  • Lymphoma
  • Therapy
  • United States
  • Kyowa Hakko Kirin Co., Ltd.
  • Clinical Trial profile. 500 Trial Title
  • 5. All the trials included are unique trials.
  • Clinical Trial
  • Dementia
  • Hospital
  • Neurology
  • Pharmaceutical
  • KYOWA HAKKO KIRIN CO., LTD.
  • PIPELINE BY JOHNSON & JOHNSON, H1 2018
  • Monoclonal Antibody
  • Therapy
  • United States
  • World
  • Product Initiative
  • KYOWA HAKKO KIRIN CO LTD
  • bleselumab
  • Monoclonal Antibody
  • Therapy
  • United States
  • World
  • Product Initiative
  • ASSET PURCHASE

IT SPECIALIZES IN AGE-RELATED DISORDERS.

  • Healthcare
  • Pharmaceutical
  • Company
  • M&A
  • Aspen Pharmacare Holdings Limited
  • 7.1 GOVERNMENT

personality disorder, and addiction.

  • Data Analytics
  • Software
  • World
  • Affectiva, Inc.
  • Emotient, Inc.
  • ACTIVIOMICS ENTERS INTO RESEARCH AGREEMENT WITH KYOWA HAKKO
  • ACTIVIOMICS EXTENDS RESEARCH AGREEMENT WITH KYOWA HAKKO KIRIN

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Healthcare
  • Influenza
  • Pharmaceutical
  • United Kingdom
  • hVIVO plc
  • Kyowa Hakko Kirin Co., Ltd.
  • Antimalarials
  • Infectious Disease
  • Pharmaceutical
  • Vaccine
  • World
  • IO BIOTECH APS
  • PIPELINE BY IO BIOTECH APS, H1 2017
  • Cancer
  • Research And Development
  • Therapy
  • United States
  • Incyte Corporation
  • Clinical Trial profile. 102 Trial Title
  • Official Title
  • Clinical Trial
  • Drug Discovery And Development
  • Hospital
  • Neurology
  • Pharmaceutical
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Disorder, Schizophrenia Ongoing, recruiting Phase II Interventional PF-## Yale University National Center for Advancing Translational Sciences ## Aug 2013 ## Jul 2018 ## ## ## Sodium And Chloride Dependent Glycine Transporter ## (Glyt## or Solute Carrier Family ## Member ## or SLC##A##) Inhib

  • Clinical Trial
  • Drug Discovery And Development
  • Neurology
  • Psychotic Disorder
  • World
  • AES AT ≥5% INCIDENCE IN ADULT SCHIZOPHRENIA TRIALS OF ZYPREXA
  • OTHER SCHIZOPHRENIA SPECTRUM DISORDERS, 2015
  • Antipsychotic
  • Hospital
  • Mental Health
  • Psychotic Disorder
  • Therapy
  • SANFORD HEALTH ACQUIRES HEMATECH, DRUG DEVELOPMENT COMPANY

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Health Services
  • Healthcare
  • Pharmaceutical
  • United States
  • GlobalData's company
  • KYOWA HAKKO KIRIN CO LTD
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H2 2017

It specializes in age-related disorders.

  • Dementia
  • Pain Relief
  • Pharmaceutical
  • Therapy
  • Flex Pharma, Inc.
  • Clinical Trial profile. 197 Trial Title
  • Prominent Drugs
  • Addictions
  • Neurology
  • Opioid
  • Therapy
  • Alkermes plc
  • PIPELINE BY KYOWA HAKKO KIRIN CO LTD, H2 2017
  • PIPELINE BY MEDIMMUNE LLC, H2 2017

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative
  • MedImmune, LLC
  • INCYTE CORP
  • PIPELINE BY INCYTE CORP, H1 2018

Its development pipeline consists of various protein, antibody and small molecule formulations for the treatment of neutropenia, anemia, chronic idiopathic thrombocytopenic purpura, hypertension, angina pectoris, allergic rhinitis, epilepsy, behavioral or personality disorders and

  • Monoclonal Antibody
  • Oncology
  • Therapy
  • United States
  • Product Initiative